FMRP is highly expressed in human breast cancer and distal metastasis FMRP expression on human TMAs containing normal and multi‐tumour tissues. FMRP is.

Slides:



Advertisements
Similar presentations
Expression profiles for prognosis and prediction Laura J. Van ‘t Veer The Netherlands Cancer Institute, Amsterdam.
Advertisements

(+++) Normal breast ATM (++) IDC ATM Lymph node metastasis negative positive P-value A B X200 C Vector ATM - WT.
Appendix Supplementary data (online only) to: Marleen Kok, Wilbert Zwart, Caroline Holm, Renske Fles, Michael Hauptmann, Laura J. Van ’t Veer, Lodewyk.
Supplemental Figures Loss of circadian clock gene expression is associated with tumor progression in breast cancer Cristina Cadenas 1*, Leonie van de Sandt.
Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.
Volume 14, Issue 10, Pages (March 2016)
Number of brain metastasis
Training Set Clinicopathological parameters of the training set
  TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson
Figure 1. MORT gene silencing is early event in cancer
Supplementary Table 1. (A) S100β Validation set (n=76 ER-positive and ER-negative patients). (B) S100β Validation set (n=59 ER-positive patients). Association.
Figure S1. DCYTB expression is higher in ER+ than ER- patients
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
MiR‐10b* down‐regulates the expression of BUB1, PLK1 and CCNA2 proteins in breast cancer cell lines.A.SPIN‐ordered expression matrix of miR‐10b* and its.
Regional lymph nodes and distal extracranial metastases are not a reliable surrogate for actionable mutation in brain metastases. Regional lymph nodes.
A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer  Gen Wang, Xiaosong.
BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.
ECM29 mediates palbociclib‐induced proteasomal activation and may function as a putative biomarker for palbociclib treatment efficacy in breast cancer.
Triple‐negative breast cancer (TNBC) cells in human express a specific gene signature and their self‐renewal depends on canonical Wnt/β‐catenin signalling.A.Human.
Human triple‐negative breast cancers (TNBC) express WNT10B, show active Wnt signalling and have high proliferation, and WNT10B has clinical relevance and.
IRE1 signaling signatures in glioblastoma multiform
Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 
ECM 29 and Kaplan–Meier survival curves for additional datasets
Volume 20, Issue 6, Pages (December 2011)
IRE1 signaling signatures in glioblastoma multiform
Expression of CD36 and psap in a TMA of human ovarian cancer patients
SPP1 and TNC are induced by active JNK and promote lung metastasis
JNK signaling mediates mammary tumor growth and metastasis to lungs
Marker reproducibility and metastasis prediction performance.
SPRY2 deficiency mediates CRPC
T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived model in a CXCR4‐dependent manner T22‐GFP‐H6‐FdU prevents metastasis in the M5 patient‐derived.
SPRY2 deficiency‐induced SRB1 mediates CRPC
Inhibition of JNK signaling sensitizes mammary tumors and metastases to chemotherapy Inhibition of JNK signaling sensitizes mammary tumors and metastases.
Christina I. Selinger, PhD, Wendy A
Association of AIM2, RIG‐I and NLRP3 inflammasomes with better survival in NPC patients.A.Overexpression of ASC, caspase‐1 and IL‐1β proteins as well as.
Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+ tumors Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+
Triple‐negative human breast cancers specifically express high levels of nuclear HMGA2, whose expression has clinical relevance and predicts recurrence‐free.
Volume 14, Issue 10, Pages (March 2016)
Apc deletion within the renal epithelium leads to rapid deletion of recombined cells and an upregulation of senescent markers.A and B. Kidneys imaged on.
Fmrp regulates E‐cadherin and Vimentin in breast cancer cells Fmrp (red) and E‐cadherin (green) detection by I.F. in 4T1 cells expressing different Fmrp.
TGFβ signaling activity in smooth muscle cells in human left main coronary arteries with various degrees of atherosclerosis TGFβ signaling activity in.
BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.
GPRC5A is hypoxia/HIF‐induced in vivo
Subnetworks enriched for the hallmarks of cancer.
Assessment of proliferation status of PDGFRα+ cells in developing mouse lungs Assessment of proliferation status of PDGFRα+ cells in developing mouse lungs.
Combined targeting of PCa AR and CCL2/CCR2 axis suppresses tumour growth and reduces metastasis in a xenograft mouse PCa model Proliferation assay of TRAMP‐C1.
The antitumor activity of olaparib in PDXs identifies a subset of PARPi‐sensitive tumors The antitumor activity of olaparib in PDXs identifies a subset.
Fig. 3 CSF1 is expressed in human melanoma.
ZBTB48 is required for MTFP1 expression
High CDK6 expression predicts poor prognosis in EOC patients
The Mucinous Lung Tumor Signature is highly enriched in colorectal, stomach, pancreatic, lung (adenocarcinoma; LUAD), and breast cancers The Mucinous Lung.
Genomewide profiling of chromatin accessibility in prostate cancer specimens Genomewide profiling of chromatin accessibility in prostate cancer specimens.
Effect of D‐Asp treatment on myelination and remyelination in cerebellar organotypic slices Effect of D‐Asp treatment on myelination and remyelination.
Quantification of MHC-I, β2m, and T-cell subsets.
Nilotinib inhibits DDR1 invasive activity of patient‐derived CRC cells
ADAM8 is overexpressed in human breast cancer AADAM8 mRNA expression in samples from breast tumor and normal breast tissue was analyzed using the Oncomine.
Tangle formation and downregulation of miR‐132‐3p in LOAD A‐G
Bevacizumab therapy leads to reduced vessel density and increased Ang‐2 expression Bevacizumab therapy leads to reduced vessel density and increased Ang‐2.
SPRY2 deficiency mediates CRPC
Expression of RUNX2 correlates with ER/PR/HER2-negative human breast cancer. Expression of RUNX2 correlates with ER/PR/HER2-negative human breast cancer.
Correlation between Pten/p53 status and AKT pathway activity in BC and effect on clinical outcome Box plot for p53‐pathway activity in p53 wild‐type and.
Volume 2, Issue 3, Pages (March 2016)
Correlation of RSPO expression to LGR5 expansion in gastric cancer.
Associations between the differences in BDNF or TrkB mRNA expression and in GAD67 mRNA expression across subject pairs. Associations between the differences.
Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,
AXL is not expressed in human prostate tumors.
IL-13Rα2 expression is associated to human colon cancer progression and poor survival of patients with colorectal cancer. IL-13Rα2 expression is associated.
EN1 expression in breast cancer and clinical outcome.
SAF-1 expression in clinical breast cancer tissues.
Detection of E-cadherin fragments in human prostate cancer metastases.
Presentation transcript:

FMRP is highly expressed in human breast cancer and distal metastasis FMRP expression on human TMAs containing normal and multi‐tumour tissues. FMRP is highly expressed in human breast cancer and distal metastasis FMRP expression on human TMAs containing normal and multi‐tumour tissues. (n), number of samples; (N), normal; (T), tumour tissue; (%), percentage of FMRP positive tissues (p = 0.015, contingency table analysis with Pearson chi‐square test was applied (JMPTM IN 5.1).FMRP and α‐tubulin expression in normal breast and ductal carcinoma revealed by Western blotting analysis. (n = 7 pairs, p < 0,01).FMRP expression on a TMA (Confalonieri et al, 2009) from human breast tumour (n = 477). *Not all clinical parameters were available. The number of cases with weak‐moderate FMRP level (FMRP‐IHC ≤ 1.0) and the number of cases with very high level of FMRP (FMRP‐IHC > 1.0) as well as the percentage of FMRP positive cases (%) is reported in each patients subgroup and for each clinico‐pathological parameter analysed. FMRP significantly correlates with high tumour grade (p = 0.004), high proliferation index (Ki67, p < 0.001) and negative lymph node status (p < 0.001).Representative images of FMRP expression in normal and tumour breast tissues including the margin of a breast primary tumour (overview and detail). Scale bars: 100 µm (panels 1‐2‐3) and 50 µm (panel 4).FMR1 mRNA expression in breast primary tumours on four different breast cancer datasets: TRANSBIG (Desmedt et al, 2007), EMC‐344 (Wang et al, 2005), MSK‐99 (Minn et al, 2007) and NKI‐295 (van de Vijver et al, 2002). Pts (n), number of patients. For the TRANSBIG dataset, FMR1 mRNA level was calculated as a percentage of increased expression respect to non metastatic tumours, and for tumours nonmetastatic to lung for the EMC‐344, MSK‐99, NKI‐295 cohorts using Welch's t‐test. NC, not changed.Kaplan–Meier curves for the probability of having metastasis to lung. Pts, number of patients; n, number of patients in each subgroup: (low FMR1 mRNA levels in red and high levels in blue); events, number of patients with lung metastasis in those two subgroups. Left curve: all datasets metastatic to the lung (Pts = 639 excluding TRANSBIG), middle curve: NKI‐295 node‐negative dataset, right: NKI‐295 node‐positive dataset, p‐values were calculated using the Log‐rank test.FMR1 mRNA expression was compared amongst the TNBC group (i.e. ER/PgR and HER2 negative) and the ER/PgR (p < 0.0001) and/or the HER2 positive (p = 0.0007) (Pts = 597).FMRP expression in primary breast tumours and matched lung metastases (n = 12, p < 0.01). Representative images of IHC for FMRP and quantification are shown. Scale bars: 50 μm. Rossella Lucá et al. EMBO Mol Med. 2013;5:1523-1536 © as stated in the article, figure or figure legend